• Published 2 Dec 2025

Biotechnology for New Drug Modalities

  • Events

Zwingenberg, Germany | 15 April 2026 | Hosted by BRAIN Biotech AG

Key topics

Recent advances in computational biology are transforming the way drugs are discovered, designed and manufactured. From AI-supported protein modelling to data-driven bioprocess optimisation, new digital tools are reshaping the boundaries of what is possible in modern therapeutics.

This one-day seminar will bring together experts from industry and academia to examine these developments in depth, sharing practical insights into emerging technologies, current limitations, and the trends defining the future of biotechnology for new drug modalities.

What You Can Expect

Throughout the event, we will cover:

  • Integrated Expertise Across Modalities
  • Tackling Non-Druggable Targets
  • AI-Supported Enzyme and Protein Design
  • Enzymatic Manufacturing of Oligonucleotides
  • LLMs and Machine Learning for Protein Design
  • Future Outlook for AI in Biocatalysis
  • Case insights illustrating real-world problem solving

This structured seminar combines expert presentations with interactive discussion, delivering content that is both technically rigorous and directly relevant to your work.

Why Attend

This conference will equip attendees with:

  • Insight into enzyme discovery strategies suited to advanced modalities
  • Perspectives on protein engineering for complex functional requirements
  • Approaches to host strain optimisation beyond conventional systems
  • Methods for designing enzymes that perform under process conditions
  • Practical considerations for bridging discovery with scalable production

Whether you are involved in early discovery, process development, or biomanufacturing strategy, this event will offer technical depth and actionable insights tailored to the challenges of next-generation therapeutic development.

Who Should Join

This event is designed for professionals working in:

  • Pharmaceutical and biotech R&D
  • Enzyme discovery and engineering
  • Process and bioprocess development
  • Strain optimisation and fermentation
  • Technical leadership in advanced modalities

Attendees will have the opportunity to engage with speakers and peers, exchange practical insights, and deepen their understanding of how enzyme technologies can support emerging therapeutic formats.

Register

Please register for this event using the form on the BRAINBiocatalysts event page here: https://www.biocatalysts.com/media-resources/brainbiocatalysts-conference-drug-modalities

Resources & Insights

  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders
  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders